Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies (original) (raw)
Laing SP, Swerdlow AJ, Slater SD et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765 ArticleCASPubMed Google Scholar
Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB (2013) Impact of diabetes on cardiovascular disease: an update. Int J Hypertens 2013:653789 ArticlePubMed CentralPubMed Google Scholar
Fox CS, Coady S, Sorlie PD et al (2004) Trends in cardiovascular complications of diabetes. JAMA 292:2495–2499 ArticleCASPubMed Google Scholar
Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319–323 ArticleCASPubMed Google Scholar
Ninomiya T, Perkovic V, de Galan BE et al (2009) Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20:1813–1821 ArticlePubMed CentralPubMed Google Scholar
Targher G, Zoppini G, Chonchol M et al (2011) Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals. Nutr Metab Cardiovasc Dis 21:294–301 CASPubMed Google Scholar
Sarnak MJ, Astor BC (2011) Implications of proteinuria: CKD progression and cardiovascular outcomes. Adv Chronic Kidney Dis 18:258–266 ArticlePubMed Google Scholar
Astor BC, Matsushita K, Gansevoort RT et al (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79:1331–1340 ArticleCASPubMed Google Scholar
Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE (2008) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes. J Nephrol 21:566–569 CASPubMed Google Scholar
Schrader J, Lüders S, Kulschewski A, MARPLE Study Group et al (2006) Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J Hypertens 24:541–548 ArticleCASPubMed Google Scholar
Usui T, Ninomiya T, Nagata M, Doi Y, Hata J, Fukuhara M, Kiyohara Y (2011) Albuminuria as a risk factor for peripheral arterial disease in a general population: the Hisayama study. J Atheroscler Thromb 18:705–712 ArticleCASPubMed Google Scholar
Vlek AL, van der Graaf Y, Spiering W, Algra A, Visseren FL (2008) Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease. J Intern Med 264:351–360 ArticleCASPubMed Google Scholar
Hillege HL, Fidler V, Diercks GF, Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777–1782 ArticleCASPubMed Google Scholar
Konta T, Kudo K, Sato H et al (2013) Albuminuria is an independent predictor of all-cause and cardiovascular mortality in the Japanese population: the Takahata study. Clin Exp Nephrol 17:805–810 ArticleCASPubMed Google Scholar
Schmieder RE, Mann JF, Schumacher H et al (2011) Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol 22:1353–1364 ArticlePubMed CentralPubMed Google Scholar
Spoelstra-de Man AM, Brouwer CB, Stehouwer CD, Smulders YM (2001) Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care 24:2097–2101 ArticleCASPubMed Google Scholar
Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ (2003) Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med 20:277–282 ArticleCASPubMed Google Scholar
Zandbergen AA, Vogt L, de Zeeuw D et al (2007) Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria. Diabetes Care 30:3119–3121 ArticleCASPubMed Google Scholar
Estacio RO, Dale RA, Schrier R, Krantz MJ (2012) Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension. Am J Cardiol 109:1743–1748 ArticleCASPubMed Google Scholar
De Zeeuw D, Remuzzi G, Parving HH et al (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110:921–927 ArticlePubMed Google Scholar
Teo K, Yusuf S, Sleight P et al (2004) Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J 148:52–61 ArticlePubMed Google Scholar
Yusuf S, Teo K, Anderson C et al (2008) Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 372:1174–1183 ArticleCASPubMed Google Scholar
Yusuf S, Teo KK, Pogue J et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547–1559 ArticleCASPubMed Google Scholar
Barzilay JI, Gao P, Ryden L et al (2011) Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study. Diabetes Care 34:1902–1907 ArticleCASPubMed CentralPubMed Google Scholar
Mann JF, Schmieder RE, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372:547–553 ArticleCASPubMed Google Scholar
Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612 ArticlePubMed CentralPubMed Google Scholar
Vuong QH (1989) Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica 57:307–333 Article Google Scholar
Schmieder RE, Schrader J, Zidek W et al (2007) Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 96:247–257 ArticleCASPubMed Google Scholar
Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32–35 ArticleCASPubMed Google Scholar
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145–153 ArticleCASPubMed Google Scholar
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997 Article Google Scholar
Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321 ArticlePubMed Google Scholar
Redon J, Mancia G, Sleight P et al (2012) Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol 59:74–83 ArticlePubMed Google Scholar
Danaei G, Singh GM, Paciorek CJ et al (2013) The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation 127:1493–1498 ArticlePubMed Google Scholar
Meigs JB (2010) Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009. Diabetes Care 33:1865–1871 ArticlePubMed CentralPubMed Google Scholar
Stehouwer CD, Smulders YM (2006) Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 17:2106–2111 ArticleCASPubMed Google Scholar
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219–226 ArticleCASPubMed Google Scholar
Viberti G, Wheeldon NM (2002) Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation 106:672–678 ArticleCASPubMed Google Scholar
Blacklock CL, Hirst JA, Taylor KS, Stevens RJ, Roberts NW, Farmer AJ (2011) Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in type 2 diabetes: a meta-analysis. Diabet Med 28:1182–1187 ArticleCASPubMed Google Scholar
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357 ArticleCASPubMed Google Scholar
Gansevoort RT, Verhave JC, Hillege HL et al; PREVEND Study Group (2005) The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl:S28–S35
Viana LV, Gross JL, Camargo JL, Zelmanovitz T, da Costa Rocha EP, Azevedo MJ (2012) Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes. J Diabetes Complicat 26:407–412 ArticlePubMed Google Scholar
Justesen TI, Petersen JL, Ekbom P, Damm P, Mathiesen ER (2006) Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes. Diabetes Care 29:924–925 ArticlePubMed Google Scholar